Supernus Pharmaceuticalsincis A Biopharmaceutical Company Based In Rockvillemarylandfocused On Developing Treatments For Central Nervous Systemcnsdisordersfounded In 2005The Company Went Public In 2012 And Has Over 30 Years Of Expertise In Cns Drug Developmentsupernus Specializes In Therapies For Conditions Such As Epilepsyparkinsonae S Diseaseadhdand Cervical Dystoniautilizing Proprietary Technologies For Drug Delivery The Companyae S Product Lineup Includes Oxtellar Xr For Partial Seizurestrokendi Xr For Epilepsy And Migraine Preventionand Therapies For Parkinsonae S Disease Like Apokyn And Xadagoadditionallymyobloc Is Used For Cervical Dystonia And Sialorrheasupernus Is Also Advancing Its Pipeline With Candidates Like Spn 830Spn 817Spn 443And Spn 448Targeting Various Neurological And Psychiatric Indications Supernus Serves Pharmaceutical Wholesalersspecialty Pharmaciesand Distributorswith Its Products Prescribed By Healthcare Providersthe Company Holds 104 Patents Related To Cns Drug Formulations And Treatment Methodsemphasizing Its Commitment To Innovation In This Field
